Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion type Assertion NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_head.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion description "[To understand the molecular basis of drug resistance observed in brain tumors, we examined the relationship between alteration of p16, a cyclin dependent kinase inhibitor whose functions are frequently lost in many human gliomas, and chemosensitivity of tumor cells to various kinds of anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_provenance.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion evidence source_evidence_literature NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_provenance.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion SIO_000772 10938390 NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_provenance.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion wasDerivedFrom befree-20140225 NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_provenance.
- NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_assertion wasGeneratedBy ECO_0000203 NP702199.RAfIlasehNTdSnQ0lgfOhmVNiQ6V-RJo_OMFLgau07KA0130_provenance.